Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (675) 675
Book Chapter (24) 24
Book / eBook (4) 4
Magazine Article (2) 2
Newsletter (2) 2
Transcript (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
amyloidosis (563) 563
science & technology (304) 304
life sciences & biomedicine (280) 280
humans (272) 272
physical fitness (226) 226
research (185) 185
male (153) 153
female (131) 131
alzheimer's disease (125) 125
animals (115) 115
medical research (109) 109
medicine, experimental (105) 105
middle aged (105) 105
care and treatment (90) 90
proteins (85) 85
amyloidosis - complications (71) 71
adult (70) 70
biochemistry & molecular biology (68) 68
amyloid (65) 65
aged (62) 62
analysis (61) 61
amyloidosis - pathology (60) 60
biological and medical sciences (59) 59
medical sciences (55) 55
mice (52) 52
prognosis (52) 52
amyloidosis - etiology (49) 49
neurosciences (49) 49
diagnosis (46) 46
disease models, animal (43) 43
drug therapy (43) 43
health aspects (43) 43
amyloidosis - diagnosis (42) 42
general & internal medicine (41) 41
amyloidosis - drug therapy (40) 40
medicine, general & internal (40) 40
neurosciences & neurology (40) 40
inflammation (39) 39
biopsy (38) 38
medicine & public health (37) 37
brain (36) 36
amyloidosis - metabolism (35) 35
genetic aspects (35) 35
neurodegenerative diseases (35) 35
alzheimer’s disease (34) 34
medicine, research & experimental (34) 34
mutation (34) 34
research & experimental medicine (34) 34
risk factors (34) 34
cancer (33) 33
peptides (33) 33
transthyretin (32) 32
alzheimers disease (31) 31
diabetes (31) 31
retrospective studies (31) 31
physiological aspects (30) 30
transplantation (30) 30
kidney diseases (29) 29
mice, transgenic (29) 29
treatment outcome (29) 29
alzheimer disease - metabolism (27) 27
amyloidosis - therapy (27) 27
cardiac patients (27) 27
medicine (27) 27
patients (27) 27
review (27) 27
abridged index medicus (26) 26
amyloid - metabolism (26) 26
chemistry (25) 25
chemotherapy (25) 25
development and progression (25) 25
multiple myeloma (25) 25
urology & nephrology (25) 25
mortality (24) 24
pathology (24) 24
rodents (24) 24
science & technology - other topics (24) 24
disease (23) 23
familial mediterranean fever (23) 23
multidisciplinary sciences (23) 23
pathogenesis (23) 23
alzheimer disease - pathology (22) 22
heart failure (22) 22
metabolic diseases (22) 22
neurology (22) 22
physical sciences (22) 22
amyloidosis - physiopathology (21) 21
biomarkers (21) 21
genetic engineering (21) 21
heart (21) 21
patient outcomes (21) 21
time factors (21) 21
amyloid beta-peptides - metabolism (20) 20
amyloidogenesis (20) 20
animal models (20) 20
brain - metabolism (20) 20
cardiovascular system & cardiology (20) 20
insulin (20) 20
nephrology (20) 20
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (702) 702
Japanese (3) 3
Spanish (3) 3
French (2) 2
German (2) 2
Croatian (1) 1
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Natural product-based amyloid inhibitors
by Velander, Paul and Wu, Ling and Henderson, Frances and Zhang, Shijun and Bevan, David R and Xu, Bin
Biochemical pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 40 - 55
Covalent mechanisms | Non-covalent mechanisms | Amyloid inhibitor | Natural products | Inhibition mechanisms | Amyloidosis - prevention & control | Drugs, Investigational - pharmacology | Antioxidants - chemistry | Nootropic Agents - metabolism | Antioxidants - metabolism | Healthy Diet | Humans | Polyphenols - pharmacology | Drugs, Investigational - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Biological Products - pharmacology | Flavonoids - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Polyphenols - metabolism | Amyloidogenic Proteins - antagonists & inhibitors | Drugs, Investigational - chemistry | Protein Aggregation, Pathological - prevention & control | Amyloidosis - diet therapy | Drug Design | Flavonoids - pharmacology | Protein Aggregation, Pathological - diet therapy | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Chelating Agents - therapeutic use | Biological Products - therapeutic use | Chelating Agents - chemistry | Nootropic Agents - therapeutic use | Amyloidosis - drug therapy | Antioxidants - pharmacology | Chelating Agents - pharmacology | Nootropic Agents - chemistry | Drug Discovery | Protein Aggregation, Pathological - drug therapy | Amyloidogenic Proteins - metabolism | Antioxidants - therapeutic use | Biological Products - chemistry | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Flavonoids - metabolism | Polyphenols - chemistry | Biological Products - metabolism | Polyphenols - therapeutic use | Chelating Agents - metabolism | Dietary Supplements | Flavonoids - chemistry | Amyloidosis - metabolism | Nootropic Agents - pharmacology | Medicine, Experimental | Medical research | Nervous system diseases | Glycoproteins | Drug discovery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis
by Melnikova, Tatiana and Fromholt, Susan and Kim, HyunSu and Lee, Deidre and Xu, Guilian and Price, Ashleigh and Moore, Brenda D and Golde, Todd E and Felsenstein, Kevin M and Savonenko, Alena and Borchelt, David R
The Journal of neuroscience, ISSN 0270-6474, 02/2013, Volume 33, Issue 9, pp. 3765 - 3779
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Alzheimer Disease - complications | Humans | Memory, Short-Term - physiology | Subcellular Fractions - pathology | Alzheimer Disease - pathology | Brain - metabolism | Doxycycline - administration & dosage | Time Factors | Amyloidosis - diet therapy | Amyloidosis - genetics | Cognition Disorders - etiology | Reaction Time - drug effects | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | Brain - ultrastructure | Space Perception | Amyloidosis - complications | Plaque, Amyloid - diet therapy | Disease Models, Animal | Peptide Fragments - metabolism | Amyloidosis - pathology | Enzyme-Linked Immunosorbent Assay | Maze Learning - physiology | Plaque, Amyloid - pathology | Mice, Inbred C57BL | Cognition Disorders - pathology | Memory, Short-Term - drug effects | Mice, Transgenic | Reaction Time - genetics | Maze Learning - drug effects | Mutation - genetics | Subcellular Fractions - metabolism | Phenotype | Amyloid beta-Protein Precursor - genetics | Animals | Recognition (Psychology) - drug effects | Analysis of Variance | Discrimination (Psychology) - physiology | Brain - pathology | Plaque, Amyloid - metabolism | Mice | Alzheimer Disease - genetics | Cognition Disorders - diet therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Natural compounds as therapeutic agents for amyloidogenic diseases
by Vassallo, Neville editor
2015, Advances in experimental medicine and biology, ISBN 3319183656, Volume 863, vii, 163
Herbs | Brain | drug therapy | Chemoprevention | Huntington's disease | Therapeutic use | Diseases | Degeneration (Pathology) | Chemotherapy | pharmacology | Polyphenols | Biological Products | Amyloidosis | Pharmacy | Phenols
Book
Details down arrow
4. Full Text Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation
by Aaseth, Jan and Alexander, Jan and Bjørklund, Geir and Hestad, Knut and Dusek, Petr and Roos, Per M and Alehagen, Urban
Biometals, ISSN 0966-0844, 10/2016, Volume 29, Issue 5, pp. 827 - 839
Biochemistry, general | Microbiology | Alzheimer’s disease | Neuroinflammation | Plant Physiology | Iron | Medicine/Public Health, general | Cell Biology | Life Sciences | Transmitters | Selenium | Pharmacology/Toxicology | Copper | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Alzheimer Disease - diet therapy | Animals | Selenium Compounds - administration & dosage | Inflammation - drug therapy | Humans | Alzheimer Disease - metabolism | Alzheimer Disease - drug therapy | Selenium Compounds - pharmacology | Selenium Compounds - metabolism | Oxidative Stress - drug effects | Dietary Supplements | Selenium Compounds - therapeutic use | Amyloidosis | Drug therapy | Alzheimer's disease | Amyloid beta-protein | Resveratrol | Alzheimers disease | Dietary supplements | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease
by Sung, Syuan and Yao, Yuemang and Uryu, Kunihiro and Yang, Hengxuan and Lee, Virginia M-Y and Trojanowski, John Q and Praticò, Domenico
The FASEB journal, 2004, Volume 18, Issue 2, pp. 323 - 325
Amyloidosis - prevention & control | Plaque, Amyloid - drug effects | Brain - metabolism | Alzheimer Disease - diet therapy | Time Factors | Alzheimer Disease - prevention & control | Amyloidosis - diet therapy | Amyloid beta-Peptides - metabolism | Lipid Peroxidation - drug effects | Vitamin E - therapeutic use | Disease Models, Animal | Mice, Transgenic | Antioxidants - pharmacology | Disease Progression | Brain - drug effects | Antioxidants - therapeutic use | Animals | Aging - physiology | Alzheimer Disease - metabolism | Antioxidants - administration & dosage | Vitamin E - administration & dosage | Plaque, Amyloid - metabolism | Mice | Oxidative Stress - drug effects | Dietary Supplements | Vitamin E - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases
by Ngoungoure, Viviane L. Ndam and Schluesener, Jan and Moundipa, Paul F and Schluesener, Hermann
Molecular nutrition & food research, ISSN 1613-4125, 01/2015, Volume 59, Issue 1, pp. 8 - 20
Amyloidogenesis | Amyloid fibrils | Amyloid diseases | Human diet | Natural polyphenols | Life Sciences & Biomedicine | Food Science & Technology | Science & Technology | Animals | Amyloid - metabolism | Humans | Polyphenols - pharmacology | Alzheimer Disease - drug therapy | Amyloidosis - drug therapy | Amyloid - chemistry | Phytochemicals - pharmacology | Disease Models, Animal | Polyphenols | Amyloidosis | Chemical properties | Alzheimer's disease | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Implantable defibrillators in cardiac amyloidosis
by van Galen, Karin P.M and van Dijk, Jeroen and Regelink, Josien C and Huijgens, Peter C and Minnema, Monique C and Zweegman, Sonja
International journal of cardiology, ISSN 0167-5273, 2012, Volume 165, Issue 2, pp. 371 - 373
Cardiovascular | Cardiac amyloidosis | Implantable cardioverter–defibrillator | Sudden death | Implantable cardioverter-defibrillator | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Other metabolic disorders | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Biological and medical sciences | Metabolic diseases | Intensive care medicine | Amyloidosis | Medical sciences | Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) | Emergency and intensive care: neonates and children. Prematurity. Sudden death | Amyloidosis - therapy | Heart Diseases - physiopathology | Humans | Middle Aged | Amyloidosis - physiopathology | Male | Heart Diseases - therapy | Defibrillators, Implantable | Adult | Female | Registries | Aged | Retrospective Studies | Defibrillators | Implants, Artificial | Prosthesis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Broad-Based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention
by Wolf, Andrew B and Braden, B. Blair and Bimonte-Nelson, Heather and Kusne, Yael and Young, Nicole and Engler-Chiurazzi, Elizabeth and Garcia, Alexandra N and Walker, Douglas G and Moses, Guna S.D and Tran, Hung and Laferla, Frank and Lue, Lihfen and Emerson Lombardo, Nancy and Valla, Jon
Journal of Alzheimer's disease, ISSN 1387-2877, 2012, Volume 32, Issue 1, pp. 217 - 232
Biomarkers | cytochrome-c oxidase (Complex IV) | memory | transgenic mice | sex | diet therapy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Inflammation - pathology | Nutritional Physiological Phenomena | tau Proteins - metabolism | Male | Glial Fibrillary Acidic Protein - metabolism | Psychomotor Performance - physiology | Electron Transport Complex IV - metabolism | Alzheimer Disease - diet therapy | Cognition - physiology | Female | Radiopharmaceuticals | Alzheimer Disease - psychology | Synaptophysin - metabolism | Amyloidosis - pathology | Enzyme-Linked Immunosorbent Assay | Mice, Inbred C57BL | Sex Characteristics | Maze Learning - drug effects | Mitochondrial Diseases - diet therapy | Mitochondrial Diseases - enzymology | Animals | Image Processing, Computer-Assisted | Radionuclide Imaging | Fluorodeoxyglucose F18 | Mice | Alzheimer Disease - diagnostic imaging | Dietary Supplements | Plant Extracts - therapeutic use | Index Medicus | Brain | Neuroprotection | Neurodegenerative diseases | Nutrition | Preservation | Cognitive ability | Cytochrome-c oxidase | Dietary supplements | Sex | Inflammation | Glucose | Feeding | Diets | Mitochondria | Alzheimer's disease | Steroid hormones
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy
by Russo, Massimo and Vita, Gian Luca and Stancanelli, Claudia and Mazzeo, Anna and Vita, Giuseppe and Messina, Sonia
Neuromuscular disorders : NMD, ISSN 0960-8966, 2016, Volume 26, Issue 6, pp. 374 - 377
Neurology | TTR-FAP | Parenteral nutrition | Familial amyloid polyneuropathy | Nutritional status | modified body mass index (mBMI) | Modified body mass index (mBMI) | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Autonomic Nervous System Diseases - etiology | Amyloid Neuropathies, Familial - genetics | Humans | Middle Aged | Amyloid Neuropathies, Familial - complications | Male | Treatment Outcome | Autonomic Nervous System Diseases - diet therapy | Amyloid Neuropathies, Familial - diet therapy | Autonomic Nervous System Diseases - genetics | Amyloid Neuropathies, Familial - physiopathology | Autonomic Nervous System Diseases - physiopathology | Quality of Life | Female | Nutritional Status | Parenteral Nutrition | Medical research | Polyneuropathies | Body weight | Medicine, Experimental | Transplantation of organs, tissues, etc | Amyloidosis | Health aspects | Index Medicus
Journal Article